11-62753121-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000394807.5(ZBTB3):c.544C>T(p.Arg182Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000743 in 1,614,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000394807.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZBTB3 | NM_001370809.1 | c.544C>T | p.Arg182Cys | missense_variant | 2/2 | ENST00000394807.5 | NP_001357738.1 | |
ZBTB3 | NM_001363108.2 | c.544C>T | p.Arg182Cys | missense_variant | 2/2 | NP_001350037.1 | ||
ZBTB3 | NM_001363109.2 | c.544C>T | p.Arg182Cys | missense_variant | 2/2 | NP_001350038.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBTB3 | ENST00000394807.5 | c.544C>T | p.Arg182Cys | missense_variant | 2/2 | 1 | NM_001370809.1 | ENSP00000378286.4 | ||
ZBTB3 | ENST00000673933.1 | c.694C>T | p.Arg232Cys | missense_variant | 2/2 | ENSP00000501025.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251418Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135896
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 49AN XY: 727248
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74468
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at